Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on corporate actions and treasury share transactions for the month of March 2017, filed on April 10, 2017. The document is a compliance report under Article 11 of CVM Instruction # 358/2002, detailing the company's own transactions with its securities and derivatives.
Key Financial Metrics
The filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively reports on share volume and transaction values related to treasury stock management.
| Metric | Value |
|---|---|
| Treasury Shares (Initial Balance) | 17,840,303 (0.1135% of total) |
| Treasury Shares (Final Balance) | 14,714,346 (0.0936% of total) |
| Total Volume Sold (Shares) | 2,202,001 |
| Total Proceeds from Sales (BRL) | R$ 10,110,737.07 |
| Total Volume Bought (Shares) | 163,646 |
| Total Cost of Purchases (BRL) | R$ 2,874,513.81 |
| Net Change in Treasury Shares | -3,125,957 (Reduction) |
Material Changes
The primary material change reported is a significant reduction in the company's treasury share holdings during March 2017.
- Net Reduction: The company reduced its treasury share count by approximately 3.1 million shares, decreasing its holding from 0.1135% to 0.0936% of total outstanding shares.
- Transaction Types: The reduction was driven by the conversion of shares into ADRs (1,087,602 shares), the exercise of options, the issuance of deferred shares, and bonus shares. These were partially offset by share buybacks under the "Plan of Shares Acquisition."
- ADR Activity: The filing also details corresponding ADR activity, showing 1,087,602 ADRs created via conversion and 227,032 ADRs purchased, with 1,314,634 ADRs sold.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of specific securities transactions.
Investor Verification Checklist
- Verify the impact of the 3.1 million share reduction on earnings per share (EPS) and total outstanding share count in the subsequent quarterly report.
- Confirm the pricing of the "Plan of Shares Acquisition" buybacks (approx. R$ 17.30 - R$ 17.79) against the market price during March 2017.
- Review the full Q1 2017 earnings release to understand the context of the option exercises and deferred share issuances.
- Check for any related party transactions or executive compensation details associated with the option exercises and bonus shares listed.